Explore
MedicinePOM

Pazopanib

A kinase inhibitor tablet used to treat advanced kidney cancer and soft tissue sarcoma.

Clinical information

Common uses

  • advanced renal cell carcinoma (kidney cancer)
  • advanced soft tissue sarcoma after chemotherapy

Common side effects

  • diarrhoea
  • high blood pressure
  • hair colour changes
  • feeling sick and vomiting
  • loss of appetite

Cautions

  • boxed warning: severe, sometimes fatal liver toxicity — regular liver tests needed
  • can cause heart rhythm and heart function problems
  • serious bleeding and blood clot events can occur
  • can harm an unborn baby — effective contraception needed

Interactions

  • strong CYP3A4 inhibitors (avoid or reduce dose)
  • strong CYP3A4 inducers (avoid)
  • simvastatin (raises risk of liver enzyme rises)
  • antacids, PPIs and other acid reducers (avoid)
  • narrow-margin medicines broken down by CYP3A4, 2D6 or 2C8

Pregnancy: avoid — can harm an unborn baby

Reference information, not medical advice — always follow your doctor or pharmacist. Source: DailyMed, dailymed.nlm.nih.gov, pazopanib label, setid d3e8dd09-d7d2-43da-8f63-bdf0ea0fcdf5 (accessed 2026-08-16)

Approved brands & formulations2

Brand nameDosage formStrengthImporterCategory
PazopanibTablet200mgPOM
PazopanibTablet400mgPOM
Old search API